Study on Improvement of Blood Glucose Control in Patients With Diabetes Type 2 Using SMBG

Status

Terminated

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01820169

Enrollment

Registered

2013-03-28

Start date

2013-04-30

Completion date

2013-12-31

Last updated

2016-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Brief summary

This clinical study is to determine if the use of structured testing, which is a blood glucose monitoring, via the Accu-Chek 360° View blood glucose analysis tool has a positive effect on the subjects overall glycemic control.

Interventions

DEVICE;Accu-Chek Compact Plus LCM bulk Japan

HbA1c would be changed by more careful control in blood glucose with SMBG.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

20 Years to No maximum

Inclusion criteria

1\. Age:= and \>20 years. 2. Intend to paticipate in this study after education of structured testing. 3.HbA1c:= and \>7.5% in the recect 2 months.

Exclusion criteria

1.Pregancy. 2. Heavy complication 3. judged unsuitable by doctor

Design outcomes

Primary

Measure	Time frame
Improvement in HbA1c in 6 months	6 months

Secondary

Measure	Time frame
1. Comparison with historical control in HbA1c change.	Baseline to 6 months
2. Change in blood gulucose.	Baseline to 6 months
3. Change in BMI.	Baseline to 6 months
4. Occurance of sever hypoglycemia.	Baseline to 6 months
5. Doctor's opinion for Accu-Chek 360° View.	Baseline to 6 months

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026